Emergex Vaccines

0 followers


Emergex, a clinical-stage, privately-held biotechnology company headquartered in Abingdon, UK, with an operating subsidiary in Doylestown, Pennsylvania, USA, is pioneering the development of 100% synthetic T cell-priming immune set-point vaccine candidates that harness and direct the body’s natural... Read more

Industries

Headquarters

Employees

Links

Org chart

Thomas Rademacher
Founder And CEO

Thomas Rademacher

Collapse
Brian Pfister
Vice President Government Affairs
Natalie Sands Fcca
Head Of Finance
László Fekete
Quality Director